Comparing treatment intensification and clinical outcomes of metformin and dipeptidyl peptidase-4 inhibitors in treatment-naïve patients with type 2 diabetes in Japan

scientific article published on 21 June 2019

Comparing treatment intensification and clinical outcomes of metformin and dipeptidyl peptidase-4 inhibitors in treatment-naïve patients with type 2 diabetes in Japan is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/JDI.13088
P932PMC publication ID6944821
P698PubMed publication ID31145536

P50authorTakeshi HoriiQ90045367
P2093author name stringKoichiro Atsuda
Makiko Iwasawa
Jyunichi Shimizu
P2860cites workGlucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetesQ46691051
Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness studyQ50220965
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial.Q51478110
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone.Q51484788
Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes.Q51484798
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus.Q51489068
Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web Survey.Q52562274
Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) studyQ66829496
Patient perceptions of quality of life with diabetes-related complications and treatmentsQ24644699
Systematic Literature Review of DPP-4 Inhibitors in Patients with Type 2 Diabetes Mellitus and Renal ImpairmentQ28075368
Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension studyQ28244610
Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysisQ34031108
Diabetes oral medication initiation and intensification: patient views compared with current treatment guidelines.Q34553412
Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysisQ34648377
Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implicationsQ35141566
Relationship between the efficacy of oral antidiabetic drugs and clinical features in type 2 diabetic patients (JDDM38).Q36843917
Novel incretin-based agents and practical regimens to meet needs and treatment goals of patients with type 2 diabetes mellitusQ37911132
Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs glibenclamide monotherapy in Japanese patients with type 2 diabetesQ39895520
Gastrointestinal Adverse Events of Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-analysisQ40076275
Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: a population-based studyQ41428692
Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetesQ43299560
Efficacy of dipeptidyl-peptidase-4 inhibitors and impact on β-cell function in Asian and Caucasian type 2 diabetes mellitus patients: A meta-analysisQ43462577
Efficacy and safety of saxagliptin added to metformin in Asian people with type 2 diabetes mellitus: a randomized controlled trialQ46324400
P433issue1
P921main subjectmetforminQ19484
P304page(s)96-100
P577publication date2019-06-21
P1433published inJournal of Diabetes InvestigationQ28207066
P1476titleComparing treatment intensification and clinical outcomes of metformin and dipeptidyl peptidase-4 inhibitors in treatment-naïve patients with type 2 diabetes in Japan
P478volume11

Reverse relations

Q92544171Dose distribution and up-titration patterns of metformin monotherapy in patients with type 2 diabetescites workP2860

Search more.